PharmaShots
Jul 3, 2026, 7:30 AM
Median Technologies Receives CE Mark for eyonis LCS to Detect and Diagnose Lung Cancer
Shots: Ref: Businesswire  |  Image: Median Technologies |  Press Release Related News: Median Technologies Receives the US FDA’s 510(k) Clearance for eyonis LCS for Lung Cancer Detection and Diagnosis PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Median Technologies Receives CE Mark for eyonis LCS to Detect and Diagnose Lung Cancer appeared first on PharmaShots.
Read more
